ILCG iShares Morningstar Growth ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Price Change
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| NVDA | 15.15% |
| AAPL | 6.75% |
| AVGO | 5.64% |
| AMZN | 5.17% |
| MSFT | 4.61% |
| META | 4.57% |
| GOOGL | 4.46% |
| GOOG | 3.86% |
| LLY | 2.70% |
| TSLA | 1.99% |
ETF Analysis
Fund Overview
iShares Morningstar Growth ETF (ILCG) currently reports 328 stock positions (subject to change), placing it in the widely diversified range by holdings breadth. The top line-up is NVDA (15.15%), AAPL (6.75%), AVGO (5.64%), with NVDA as the largest single weight at 15.15%. Together, the top three holdings account for 27.54%, which suggests a more balanced distribution of weight across the portfolio, reducing single-name sensitivity at the top. Taken together, the portfolio's structure reflects a deliberate trade-off between conviction at the top and risk spreading across the broader holding set.
Profitability & Capital Efficiency
On a capital return basis, ROIC is 48.36%, WACC is 11.47%, and the economic spread is 36.90%. On balance, the portfolio's businesses are compounding at rates that meaningfully exceed what capital costs would otherwise allow. Supporting metrics show ROE at 53.89% and ROA at 17.68%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.
Valuation
On an earnings multiple basis, trailing P/E of 34.62, forward P/E of 25.11, PEG of 1.73. The spread between trailing and forward P/E is moderate, suggesting some earnings improvement is expected but not a dramatic re-rating. The PEG ratio sits in a range that most investors would consider fair — neither cheap nor obviously stretched relative to anticipated earnings. A current ratio of 2.16 suggests the holdings have sufficient short-term liquidity without excess. Combining multiples and liquidity, the portfolio appears adequately priced for its current earnings trajectory, with balance sheet health providing a degree of downside resilience.
Margins & Cash Generation
Stripping to unit economics, gross margin sits at 59.68%, operating margin at 32.23%, and free cash flow margin at 25.93%. Gross margins are healthy, suggesting solid pricing power across the underlying holdings. At this operating margin level, the portfolio's holdings demonstrate strong operational discipline and meaningful earnings leverage. The portfolio's free cash flow margin is exceptional, pointing to capital-light businesses with strong reinvestment optionality. Together, these margin readings describe a portfolio of businesses that protect profitability at every layer of the income statement.
Growth & Forward Outlook
Connecting operational trends with market expectations, TTM revenue growth of 30.36% indicating strong organic momentum at the portfolio level, while the estimated 12-month price change of 25.00%, where consensus targets suggest reasonable upside rather than a step-change rerating. At 37.9%, the projected 12-month EPS growth rate is strong enough to be a primary driver of the forward investment case rather than a peripheral supporting detail. Operating momentum and analyst expectations are related but distinct — the former is backward-looking by nature, the latter inherently speculative. Against that backdrop, the more durable question is whether operating trends can be sustained long enough for analyst expectations to be validated. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
Strong BuyThe aggregate picture across capital efficiency, valuation, growth, and cash generation builds a compelling case.
The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.